Trials / Completed
CompletedNCT00620542
CRESTOR Athero Imaging Head to Head IVUS Study
Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,333 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effects of treatment with rosuvastatin 40 mg or atorvastatin 80 mg on atherosclerotic disease burden as measured by intravascular ultrasound in patients with coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | capsule, oral, once daily |
| DRUG | Atorvastatin | capsule, oral, one daily |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2008-02-21
- Last updated
- 2012-07-16
- Results posted
- 2012-06-25
Locations
195 sites across 14 countries: United States, Argentina, Australia, Belgium, Brazil, Canada, France, Hungary, Italy, Mexico, Netherlands, Poland, Russia, Spain
Source: ClinicalTrials.gov record NCT00620542. Inclusion in this directory is not an endorsement.